References
- Versiani M., Nardi A. E., Figueira I. L. V., Stabl M. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase‐A, compared with other antidepressants and placebo. Acta Psychiatr Scand 1990; 360: 24–28
- Iwersen S., Schmoldt A. Nachweis eines neuen Antidepressivums und seiner Metaboliten. Toxichem + Krimtech 1995; 62: 56–61
- Neuvonen P. J., Pohjola‐Sintonen S., Tacke U., Vuori E. Five fatal cases of serotonin syndrome after moclobemide‐citalopram or moclobemide‐clomipra‐mine overdoses. Lancet 1993; 342: 1419
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–713
- Henry J. A. Serotonin syndrome. Lancet 1994; 343: 607
- Myrenfors P. G., Eriksson T., Sandsted C. S., Sjoberg G. Moclobemide overdose. J Intern Med 1993; 233: 113–115
- Spigset O., Mjörndal T., Lovheim O. Serotonin syndrome caused by a moclobemide‐clomipramine interaction. BMJ 1993; 306: 248
- Guentert T. W., Tucker G., Korn A., Pfefen J. P., Haefelfinger P., Schoerlin M. P. Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 days. Acta Psychiatr Scand 1990; 360: 91–93
- Vine R., Norman T. R., Burrows G. D. A case of moclobemide overdose. Int Clin Psychopharmacol 1988; 3: 325–326
- Heinze G., Sanchez A. Overdose with moclobemide. J Oin Psychiatry 1986; 47: 438
- Moll E., Hetzel Moclobemide W. (Ro 11–1163) safety in depressed patients. Acta Psychiatr Scand 1990; 360: 69–70
- Hacket L. P., Joyce D. A., Hall R. W., Dusci U., Ilett K. I. Disposition and clinical effects of moclobemide and three of its metabolites following overdose. Drug Invest 1993; 5: 281–284
- Henry J. A., Alexander C. A., Sener E. K. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221–224
- Vestergaard P., Gram L. F., Kragh‐Sorensen P., Bech P., Reisby N., Bolwig T. G. Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group